Gas Transfer on ILA-Activve

Efficiency of Gas Exchange Using a Miniaturized Pump Driven Veno-venous Extracorporeal Gas Exchange Device (ILA-Activve)

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01997528

Enrollment

Registered

2013-11-28

Start date

2013-11-30

Completion date

Unknown

Last updated

2013-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypercapnia

Brief summary

Oxygenatuion and decarboxylation during different settings (steps of blood flow and sweep gas flow) of extracorporeal gas exchange by ILA Activve using a jugular 22French double lumen cannula are measured.

Interventions

DEVICEChange of blood flow or sweep gas flow ( ILA Activve)

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 89 Years

Healthy volunteers

Inclusion criteria

* Patient on ILA Activve * Controlled mechanical ventilation * No spontaneous breathing

Exclusion criteria

\- Pregnancy

Design outcomes

Primary

Measure	Time frame
Blood gas analysis	Changes after every 15 min. of each setting (13 settings leading to 195 min. altogether)

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026